# CGM, fasting glucose and A1C answer different questions

Continuous glucose trends, a fasting blood sample and A1C show different time windows. How they fit together in a glucose review.

Canonical: https://velri.co/blog/cgm-vs-fasting-glucose-what-engineer-cgm-tells-provider
Publisher: Velri (https://velri.co/about)
Published: 2026-07-04
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

A continuous glucose monitor shows a stream of readings. A fasting plasma glucose test captures one point in time. A1C reflects average glucose over roughly the previous three months. They offer different views of glucose, with different uses. [1][2]

Having more readings can reveal a pattern. Diagnosis still depends on the appropriate clinical tests and interpretation. [1]

## Fasting glucose: a defined testing condition

Fasting plasma glucose is measured from a blood sample after a fasting period specified for the test. It is one of the laboratory tests used to diagnose diabetes or prediabetes. A provider commonly uses another test to confirm a diagnosis. [1]

Its strength is that the sampling conditions and interpretation are defined. It does not describe every rise and fall over the rest of the day.

## A1C: the longer view

A1C measures glucose attached to hemoglobin in red blood cells. It summarizes a longer period rather than a single meal or morning. [3]

Some conditions affecting red blood cells or hemoglobin can make A1C less reliable. A mismatch between A1C and other glucose results is a reason to investigate the difference, rather than simply choosing whichever number looks more reassuring. [1][3]

## CGM: the pattern over time

A CGM uses a wearable sensor and an app or reader to display repeated glucose measurements and trends. Device indications matter: different systems are designed for different users and monitoring needs. [2]

In its announcement of the first over-the-counter CGM, FDA explained that the system was intended for adults who did not use insulin and did not have problematic low blood sugar. It also said users should discuss the output with a provider before making medical decisions. Those details apply to that system, not automatically to every CGM. [2]

## What makes the combined review useful

A provider can compare the laboratory results with the sensor record, the device used and what was happening during the recorded period. Meals, activity and symptoms provide context for the graph.

A screenshot of one high reading leaves out duration, repetition and the rest of the record. A laboratory report adds its own units, reference information and testing conditions. Keep the original lab report and sensor record together so the review can compare the same dates and circumstances.

## Sources
[1] Diabetes Tests & Diagnosis - NIDDK. https://www.niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis
[2] FDA Clears First Over-the-Counter Continuous Glucose Monitor | FDA. https://www.fda.gov/news-events/press-announcements/fda-clears-first-over-counter-continuous-glucose-monitor
[3] Hemoglobin A1C (HbA1c) Test: MedlinePlus Medical Test. https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support